1566 related articles for article (PubMed ID: 19247024)
21. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
Chang DT; Chapman C; Shen J; Su Z; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
[TBL] [Abstract][Full Text] [Related]
22. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.
Chao YK; Chan SC; Chang HK; Liu YH; Wu YC; Hsieh MJ; Tseng CK; Liu HP
Eur J Surg Oncol; 2009 Mar; 35(3):289-94. PubMed ID: 18396384
[TBL] [Abstract][Full Text] [Related]
23. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma.
Yamamoto S; Ishihara R; Motoori M; Kawaguchi Y; Uedo N; Takeuchi Y; Higashino K; Yano M; Nakamura S; Iishi H
Am J Gastroenterol; 2011 Jun; 106(6):1048-54. PubMed ID: 21343920
[TBL] [Abstract][Full Text] [Related]
24. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
25. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.
Ishikura S; Nihei K; Ohtsu A; Boku N; Hironaka S; Mera K; Muto M; Ogino T; Yoshida S
J Clin Oncol; 2003 Jul; 21(14):2697-702. PubMed ID: 12860946
[TBL] [Abstract][Full Text] [Related]
26. Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status.
Kim MP; Correa AM; Lee J; Rice DC; Roth JA; Mehran RJ; Walsh GL; Ajani JA; Maru DM; Chang JY; Marom EM; Macapinlac HA; Lee JH; Vaporciyan AA; Rice T; Swisher SG; Hofstetter WL
Ann Thorac Surg; 2010 Sep; 90(3):884-90; discussion 890-1. PubMed ID: 20732513
[TBL] [Abstract][Full Text] [Related]
27. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus.
Rohatgi PR; Swisher SG; Correa AM; Wu TT; Liao Z; Komaki R; Walsh G; Vaporciyan A; Lynch PM; Rice DC; Roth JA; Ajani JA
Cancer; 2005 Oct; 104(7):1349-55. PubMed ID: 16130133
[TBL] [Abstract][Full Text] [Related]
28. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas.
Miyata H; Yamasaki M; Kurokawa Y; Takiguchi S; Nakajima K; Fujiwara Y; Konishi K; Mori M; Doki Y
Ann Surg Oncol; 2011 Nov; 18(12):3353-61. PubMed ID: 21537861
[TBL] [Abstract][Full Text] [Related]
29. Using pretreatment tumor depth and length to select esophageal squamous cell carcinoma patients for nonoperative treatment after neoadjuvant chemoradiotherapy.
Chao YK; Tseng CK; Wen YW; Liu YH; Wan YL; Chiu CT; Chang WC; Chang HK
Ann Surg Oncol; 2013 Sep; 20(9):3000-8. PubMed ID: 23584515
[TBL] [Abstract][Full Text] [Related]
30. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival.
Berger AC; Farma J; Scott WJ; Freedman G; Weiner L; Cheng JD; Wang H; Goldberg M
J Clin Oncol; 2005 Jul; 23(19):4330-7. PubMed ID: 15781882
[TBL] [Abstract][Full Text] [Related]
31. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
[TBL] [Abstract][Full Text] [Related]
32. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
[TBL] [Abstract][Full Text] [Related]
33. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy.
Dittrick GW; Weber JM; Shridhar R; Hoffe S; Melis M; Almhanna K; Barthel J; McLoughlin J; Karl RC; Meredith KL
Ann Surg Oncol; 2012 May; 19(5):1678-84. PubMed ID: 22045465
[TBL] [Abstract][Full Text] [Related]
34. [Long term results of esophageal epidermoid cancers in complete remission after preoperative chemo-radiotherapy].
Triboulet JP; Amrouni H; Guillem P; Vandenhaute B; Lecomte-Houcke M; Adenis A
Ann Chir; 1998; 52(6):503-8. PubMed ID: 9752498
[TBL] [Abstract][Full Text] [Related]
35. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.
Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
J Surg Oncol; 2006 Mar; 93(4):258-67. PubMed ID: 16496364
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
Duong C; Greenawalt DM; Kowalczyk A; Ciavarella ML; Raskutti G; Murray WK; Phillips WA; Thomas RJ
Ann Surg Oncol; 2007 Dec; 14(12):3602-9. PubMed ID: 17896157
[TBL] [Abstract][Full Text] [Related]
37. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
[TBL] [Abstract][Full Text] [Related]
38. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
[TBL] [Abstract][Full Text] [Related]
39. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y
J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262
[TBL] [Abstract][Full Text] [Related]
40. [The multimodality therapy of advanced inoperable esophageal carcinoma. A retrospective analysis].
Mücke R; Ziegler PG; Libera T; Klautke G; Fietkau R
Strahlenther Onkol; 2000 Aug; 176(8):350-5. PubMed ID: 10987017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
